Clinical Trials Directory

Trials / Completed

CompletedNCT04112940

Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study is part of a larger grant, for which the overall goal is to collect measurements of liquid flow through the oropharynx (i.e., mouth and throat) during swallowing. The focus of this study is to evaluate the flow of liquids of varying consistency in the head and neck cancer population.

Detailed description

Thickened liquids are commonly used as an intervention for dysphagia (swallowing impairment). However, the field lacks a clear understanding of how liquids of different consistencies behave during swallowing. In order to improve understanding of the effectiveness of altered liquid consistency for improving dysphagia, the investigators are studying liquid flow through the oropharynx. This study explores this question in individuals who have undergone radiation treatment for head and neck cancer, specifically located in the oropharynx. Participants will swallow 20% w/v barium thickened to different consistencies (thin, slightly thick, and mildly thick) using commercially available food thickeners. Swallowing will be observed under videofluoroscopy.

Conditions

Interventions

TypeNameDescription
OTHERStarch-based Thickened LiquidsBarium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.
OTHERXanthan-gum Thickened LiquidsBarium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.

Timeline

Start date
2016-12-19
Primary completion
2019-12-31
Completion
2021-03-30
First posted
2019-10-02
Last updated
2023-04-07
Results posted
2022-07-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04112940. Inclusion in this directory is not an endorsement.